Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide for long-term maintenance of anemia in CKD patients
NCT00453973Phase 2Terminated
- Sponsor
- Affymax, Inc.
- Start
- Nov 2006
- Primary completion
- Sep 2009
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 4
01
Overview
A Phase 2 trial of peginesatide in anemia, sponsored by Affymax, Inc.. Started Nov 2006; status: terminated.
02
Drugs
peginesatide
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00453973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453973.